Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Fighting COVID-19 with Saliva: SalivaBio and Salimetrics Build Infrastructure to Supply Millions of Saliva Collection Devices for Low-Cost COVID-19 Saliva Testing

SalivaBio, together with Salimetrics and the salivary bioscience community, is working with partners to provide more than two million of its Saliva Collection Aids (SCAs) as early as September. The Saliva Collection Aid (SCA) is a low-cost saliva collection device that is easy and simple for participants to use to collect a high-quality saliva sample directly into a standard laboratory tube, thus eliminating a sample processing step, often a bottleneck for a lab. The patented design of the SCA is scalable, and this additional investment by SalivaBio will increase capacity to over four million per month as early as October, with the potential of one million per day by the end of the year.


News provided by

Salimetrics

Aug 19, 2020, 03:35 ET

Share this article

Share toX

Share this article

Share toX


CARLSBAD, Calif., Aug. 19, 2020 /PRNewswire-PRWeb/ -- "How can we help?", asks Hans Schroeder, CEO of both Salimetrics LLC and SalivaBio LLC, businesses dedicated to Salivary Bioscience for more than twenty years. Together with Douglas Granger, Ph.D., founder of Salimetrics and co-editor of the recently published book by Springer, "Salivary Bioscience: Foundations of Interdisciplinary Saliva Research and Applications," and Steven Granger, Ph.D., Chief Scientific Officer at Salimetrics, the three owners have championed saliva as a non-invasive, easy to collect sample that can provide meaningful information to the diagnostic and research communities. "Our team has studied saliva – our experts know how to collect it, how to handle it, how to process it, how to test it, and working closely with the scientific community, we are connected to the leaders in the field who know how to interpret the results." Salimetrics' COVID-19 efforts include providing collection devices for molecular testing; developing a new collection device that optimizes sample collection specific for infectious disease antibody testing; working with researchers on a high-sensitivity, high-specificity COVID-19 saliva antibody test; developing its own COVID-19 saliva antibody test for serology research use only; and operating its SalivaLab with BSL-2 safety in support of the salivary bioscience research community.

Early in the COVID-19 pandemic, Salimetrics began working with researchers and companies to increase capacity for low-cost saliva-based testing alternatives. Done right, saliva is safe, fast, and easy to self-collect for most people. Demand for COVID-19 testing from other specimens, like nasopharyngeal swabs, was limited by the supply chain, and NP swab specimens are significantly more complicated and uncomfortable to collect. In contrast, SalivaBio's Saliva Collection Aid (SCA) makes saliva easy to collect; works with many different brands of standard laboratory tubes; and could be quickly scaled to support the substantial increase in needed testing capacity, making saliva a viable choice in the fight against COVID-19. "We needed to be ready", says Doug Granger, Ph.D., "so our team made the investment in infrastructure ahead of time to ensure we could be counted on when the time came." Salimetrics will have the capability to supply two million SCAs per month as early as September, four million per month as early as October, with the potential of more than twenty million per month by the end of the year. The increased capacity will come with additional investment.

"Not only is it important to match the type of oral fluid required to the test, but designing a protocol that maintains sample integrity from mouth-to-bench can be critical to a successful application."

Post this

With the FDA's recent announcement issuing an EUA to Yale for its SalivaDirect test for rapid detection of SARS-CoV-2, rapidly expanded COVID-19 saliva testing is now possible. Additional announcements by the University of Illinois and the NIH RADx initiative show that saliva is an important tool in the fight against COVID-19. Because it is easy to collect for most people, it is both possible and practical to collect saliva frequently, and Salimetrics, based on its years of dedicated experience to salivary bioscience, provides a Saliva Collection Handbook, Saliva Collection Training and collection videos to make this happen. Saliva is a complex oral fluid, and how saliva samples are collected, handled and stored prior to analysis is often misunderstood. "Not only is it important to match the type of oral fluid required to the test, but designing a protocol that maintains sample integrity from mouth-to-bench can be critical to a successful application," says Supriya Gaitonde, Ph.D., Salimetrics Senior Applications Scientist. "That's where the team at Salimetrics comes in; our SalivaBio collection devices collect the right sample type, and our validated line of methods go beyond the device itself to enable proper saliva collection methodology, handling, and transport."

SalivaBio also offers custom engineered solutions, recently developing a new collection device that optimizes sample collection specifically for infectious disease antibody testing. This device, the Saliva Collection Aid – OMT, collects an enriched fluid sample by specifically targeting collection at the gumline where antibody concentrations are the highest, thereby increasing the suitability of saliva. "The SCA-OMT has demonstrated its ability to collect samples with substantially higher concentrations of Total IgG, reducing the likelihood of inconclusive results", says Steve Granger. "This is critical for the ramp-up in COVID-19 antibody testing which is soon to come. We've leveraged our knowledge in the development of simple, elegant design solutions for collection devices. If you want to collect the right sample, at the right time, while maximizing participant compliance, we can help."

To learn more about the SalivaBio collection devices offered exclusively through Salimetrics, researchers can visit the Salimetrics website, the SalivaBio website, or contact Salimetrics' support.

About SalivaBio:
SalivaBio is dedicated to the creation of a global standard for collection devices and techniques, as well as the development of new, cutting-edge saliva collection methods to increase ease of use and participant compliance. Exclusively from Salimetrics, all SalivaBio products are extensively tested to minimize or eliminate variability from saliva collection and have been optimized for collection with participant-specific groups.

About Salimetrics:
Salimetrics assay kits and CLIA-certified testing services are used to measure salivary analytes related to stress, behavior and development, inflammation, sleep, reproduction, health and immune function. Founded in 1998 by Douglas A. Granger, Ph.D., Salimetrics, LLC supports CROs, pharmaceuticals, academic researchers and the immunodiagnostic industry around the world with innovative immunoassay products, non-invasive saliva collection methods, and laboratory testing services.

SOURCE Salimetrics

Related Links

https://salimetrics.com/

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.